Is the United States Still Dominant in the Global Pharmaceutical Innovation Network?

Open Access

Peer-reviewed

Research Article

Yuanjia Hu ,

* E-mail: yuanjiahu@umac.mo(YJH); ytwang@umac.mo (YTW)

Affiliation State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao, China
⨯
Thomas Scherngell,

Affiliation Foresight & Policy Development Department, AIT Austrian Institute of Technology, Vienna, Austria
⨯
Si Nga Man,

Affiliation State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao, China
⨯
Yitao Wang

* E-mail: yuanjiahu@umac.mo(YJH); ytwang@umac.mo (YTW)

Affiliation State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao, China
⨯

Reader Comments (0)

Centrality
Is the Subject Area "Centrality" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
United States
Is the Subject Area "United States" applicable to this article?

Thanks for your feedback.
Network analysis
Is the Subject Area "Network analysis" applicable to this article?

Thanks for your feedback.
Drug interactions
Is the Subject Area "Drug interactions" applicable to this article?

Thanks for your feedback.
Eigenvectors
Is the Subject Area "Eigenvectors" applicable to this article?

Thanks for your feedback.
Drug discovery
Is the Subject Area "Drug discovery" applicable to this article?

Thanks for your feedback.
Research laboratories
Is the Subject Area "Research laboratories" applicable to this article?

Thanks for your feedback.